DUBLIN–(BUSINESS WIRE)–The “North America Western Blotting Market 2019-2027” report has been added to ResearchAndMarkets.com’s offering.
North America western blotting market would grow at 3.80% of CAGR throughout the forecast duration 2019-2027.
The countries of the United States and Canada together form the market for western blotting in the North American region.
Surging healthcare expenditure has helped to increase the consumption of bio-based reagents in the Canadian market. Moreover, increasing investment in research-based funding by government organizations in Canada has also helped to increase the laboratory and clinical research involving the use of reagents.
In the year 2016, the ministry of health in Canada provided a funding of about $13.2 million for health projects. Increasing healthcare expenditure has become the key factor for the growth of the market, owing to the rising number of chronic diseases. In 2015, lung cancer was one of the most common cancer types in Canada, with a total number of cases counting to about 26,600.
As per ‘Canadian Cancer Statistics 2015’, about 2 in 5 Canadians were anticipated to develop cancer throughout their lifetimes. In 2015, health expenditure in Canada was estimated to be about $219.1 million, with more than 60% directed to drugs, physicians and hospitals. This has uplifted the demand for biotechnology reagents in the country.
Key Topics Covered:
1. North America Western Blotting Market – Summary
2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.2.1. Growing Number of Applications For Western Blotting
2.2.2. Growing Acceptance of Digital Western Blotting
2.3. Porter’s Five Force Analysis
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Market Drivers
2.6.1. Growing Occurrence of Hiv And Lyme Disease
2.6.2. High Demand For Proteomics
2.6.3. Rise in Applications For Western Blotting
2.7. Market Restraints
2.7.1. Advancements in Substitute Technologies
2.8. Market Opportunities
2.8.1. Industrialization of Western Blot Instruments
2.9. Market Challenges
2.9.1. Inflated Cost of Antibodies
2.9.2. Growing Research Initiatives And R&D Expenditure By Pharmaceutical And Biotechnology Companies
3. Western Blotting Market Outlook – By Product
3.1. Consumables
3.1.1. Reagents And Buffers
3.1.2. Kits
3.1.3. Other Consumables
3.2. Instruments
3.2.1. Gel Electrophoresis Instruments
3.2.2. Blotting Systems
3.2.2.1. Dry Blotting Systems
3.2.2.2. Semi-Dry Blotting Systems
3.2.2.3. Wet Blotting Systems
3.2.3. Imagers
3.2.3.1. Chemiluminescent Imagers
3.2.3.2. Fluorescent Imagers
3.2.3.3. Other Imagers
4. Western Blotting Market Outlook – By Application
4.1. Biomedical & Biochemical Research
4.2. Disease Diagnostics
4.3. Agriculture
4.4. Other Applications
5. Western Blotting Market Outlook – By End-User
5.1. Research Institutes
5.2. Pharmaceutical & Biotechnology Companies
5.3. Diagnostic Centers
5.4. Other End-Users
6. Western Blotting Market – Regional Outlook
6.1. North America
6.1.1. United States
6.1.2. Canada
7. Competitive Landscape
7.1. F. Hoffman La-Roche Ltd.
7.2. Merck Kgaa
7.3. Thermo Fisher Scientific, Inc.
7.4. Bio-Rad Technologies, Inc.
7.5. Bio-Techne Corporation
7.6. Cell Signaling Technology, Inc.
7.7. Ge Healthcare
7.8. Li-Cor, Inc.
7.9. Advansta
7.10. Azure Biosystems, Inc.
7.11. Perkinelemer, Inc.
7.12. Roche Diagnostics International, Inc.
7.13. Roche Diagnostics
7.14. Lumigen, Inc.
7.15. Rockland Immunochemicals, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/c23hd8
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900